Scientists at deCODE genetics have uncovered a rare genetic variant in the STAT6 gene that protects against asthma, a ...

This will probably contribute to the improvement of asthma control and the prevention of acute exacerbations. Triggers of acute exacerbations are generally hard to avoid. Therefore, preexisting ...

Over 40 companies are working on more than 50 therapies for severe asthma. The severe asthma market is growing due to a ...

Although COPD and asthma share similarities, recognising their differences is essential for accurate diagnosis and treatment.

Scientists at deCODE genetics, a subsidiary of Amgen, and collaborators have published a study in Journal of Allergy and ...

To effectively manage chronic respiratory diseases like asthma and COPD, early intervention and strict adherence to doctor ...

Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

AstraZeneca's first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves. The green light for ...

Millions of adolescents in Africa could be living unknowingly with asthma as cases go undiagnosed, researchers find.

It usually develops later in life than allergic asthma. Some research suggests that non-allergic asthma is more severe than other forms. Studies also indicate it is more common in women. Conditions ...

The first-in class medicine for severe asthma co-developed by AstraZeneca and Amgen is poised for accelerated approval after the US Food and Drug Administration granted it a breakthrough designation.